For the third time this yr, a affected person who’s being handled with a Sareepta Therapeutics gene remedy has died, a revelation that comes when the corporate tries to earn again with the affected person and investor confidence within the midst of a collection of security setbacks. The primary two fatalities had been teenage boys handled with the commercialized Duchenne […]